Data Pool
| Name Name of a concept, e.g. a data model concept. In contrast to terms, the name does not depend on a given context, e.g. a country-specific language. | Data Pool |
|---|---|
| Short description Informal and short human-readable definition of a concept. | CDQ connects to various data sources that offer company data, address data, bank data, or metdata |
| Description Informal and comprehensive human-readable definition of a concept. | CDQ connects to various data sources that offer company data, address data, bank data, or metdata. The CDQ Lookup enables searching for business partner data in connected data sources. |
Data sources
The CDQ Data Sharing Community uses a collaboratively managed reference data repository. This incorporates the integration of external data sources for enriching or validating business partner and address data. Examples of available data sources are 316 countries (e.g. WORLD (World), AT (Österreich, Austria, Autriche, 奥地利), BE (Belgien, Belgium, Belgique, België, 比利时)), 993 legal forms (e.g. ), and 72 active business partner data sources (e.g. Data source CDQ.POOL, Data source VIES, Data source CH.UIDR).
Global coverage index
Overview on connected public registers not considering premium sources like DNB with global coverage.
Healthcare Professional Data
In many countries healthcare professionals or doctors require a registration in a special register, respectively need to obtain a so called medical licence. Usually with a medical licence additional restrictions or allowances come along such as permits for narcotics. CDQ connects to data sources for retrieving this kind of information.
In the United States each healthcare professional (e.g. doctors) requires a valid medical license for being allowed to operate HCP. Licenses are only valid over a certain period and thus require continuous monitoring, doctors may be put on "blacklists" by the authorities as well. Additionally, data about hospitals is difficult to manage due to the vast amount of specialized departments and persons (“Prof. Dr.”) involved whose names are important to be known. Manufacturing locations of suppliers providing certain materials or substances for pharmaceutical products are to be certified and uniquely identified.